MALONDIALDEHYDE (MDA) SEBAGAI PENANDA STRESS OKSIDATIF PADA TUBUH

Authors

  • Rita Kirana Poltekkes Kemenkes Banjarmasin

Keywords:

MDA, Stress Oksidatif

Abstract

One biomarker that is often used to measure oxidative stress is Malondialdehyde (MDA). MDA is the end product of lipid peroxidation, which is the oxidation process of unsaturated fatty acids that occurs due to ROS attack on cell membranes. As a degradation product of lipid peroxidation, MDA has the potential to form adducts with various biomolecules such as proteins and DNA, which can cause cellular damage and impaired organ function (Marnett, 1999). Due to its reactive nature and easy detectability in biological samples, MDA is often used in research to measure the extent of oxidative damage and provide a clear picture of the extent to which oxidative stress affects the body. Malondialdehyde (MDA) has proven to be a very useful biomarker for measuring the level of oxidative stress in the body. As a product of lipid peroxidation, MDA provides a clear indication of the damage caused by ROS to cell membranes and other cellular components. Elevated MDA levels are often found in various degenerative diseases and medical conditions associated with oxidative stress, including cardiovascular diseases, diabetes, cancer, and neurodegenerative disorders. Therefore, measurement of MDA levels not only serves as an indicator of oxidative damage, but can also be used as a diagnostic and prognostic tool to monitor disease progression as well as the effectiveness of targeted therapies to reduce oxidative stress

References

Ayala, A., Muñoz, M. F., & Argüelles, S. (2014). Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Free Radical Research, 48(9), 1171–1187.

Halliwell, B., & Gutteridge, J. M. C. (2015). Free Radicals in Biology and Medicine (5th ed.). Oxford University Press.

Marnett, L. J. (1999). Lipid Peroxidation and Its Role in Chemically Induced Cancer. Carcinogenesis, 20(3), 361-370.

Dalle-Donne, I., Rossi, R., Giustarini, D., & Lipozenčić, J. (2006). Biomarkers of Oxidative Stress in Human Diseases. Clinical Chemistry and Laboratory Medicine (CCLM), 44(6), 668–680.

Huang, Z., Xu, Q., & Li, S. (2009). Malondialdehyde and 4-Hydroxynonenal as Biomarkers of Oxidative Stress in Disease. Free Radical Biology and Medicine, 47(5), 609-618.

Sies, H. (2015). Oxidative Stress: A Concept in Redox Biology and Medicine. Redox Biology, 4, 180–183.

Yoshida, Y., Aizawa, T., & Okamoto, Y. (1996). Formation of Malondialdehyde from Polyunsaturated Fatty Acids. Free Radical Biology and Medicine, 21(6), 817–824.

Dalle-Donne, I., Rossi, R., Giustarini, D., & Lipozenčić, J. (2006). Biomarkers of Oxidative Stress in Human Diseases. Clinical Chemistry and Laboratory Medicine (CCLM), 44(6), 668–680.

Liu, X., Yang, M., & Liu, L. (2013). Role of oxidative stress in diabetes and its complications: A review. Biochemistry & Pharmacology, 84(6), 715-723.

Miller, R. G., & Peltier, W. (2005). Oxidative Stress and Neurodegeneration. Free Radical Biology and Medicine, 39(6), 755–763.

Zhang, H., Jiang, W., & Zhao, X. (2014). Malondialdehyde (MDA) as a Diagnostic and Prognostic Biomarker in Cancer. Cancer Biomarkers, 14(2), 91-103.

Jiang, Y., Li, H., & Lu, M. (2015). Measurement of Malondialdehyde (MDA) and Its Applications in Research. Biochimica et Biophysica Acta (BBA) - General Subjects, 1850(7), 1007-1014.

Gutteridge, J. M. C., & Halliwell, B. (2010). Free Radicals and Antioxidants: A Review. Free Radical Research, 44(10), 1240–1255.

Niki, E. (2014). Lipid Peroxidation: Physiological Levels and the Effects of Antioxidants. Free Radical Research, 48(7), 760–773.

Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for Lipid Peroxides in Animal Tissues by Thiobarbituric Acid Reaction. Analytical Biochemistry, 95(2), 351–358.

Sharma, P., et al. (2013). "Oxidative stress and cardiovascular diseases." European Journal of Clinical Nutrition, 67(1), 1-12.

Gulec, M., et al. (2010). "Malondialdehyde as a marker of oxidative stress in patients with coronary artery disease." Heart & Vessels, 25(2), 169-173.

Jaiswal, S., et al. (2016). "Oxidative stress and kidney disease: Role of malondialdehyde." International Journal of Nephrology and Renovascular Disease, 9, 201-209.

López, M. G., et al. (2016). "Malondialdehyde and antioxidant enzyme activity in Alzheimer's disease." Journal of Alzheimer's Disease, 52(2), 599-607.

Ghosh, A., et al. (2015). "Oxidative stress in Parkinson's disease: A review of the role of malondialdehyde." Journal of Neuroscience Research, 93(8), 1222-1231.

Gonçalves, D. L., et al. (2013). "Oxidative stress in cancer and its role in the diagnosis and prognosis of the disease." Cancer Cell International, 13(1), 35.

Gupta, S. C., et al. (2014). "Oxidative stress and cancer: Role of antioxidants in cancer therapy." Oxidative Medicine and Cellular Longevity, 2014, 631-640.

Kaya, M. G., et al. (2014). "The relationship between oxidative stress and diabetes mellitus." Acta Diabetologica, 51(6), 1015-1020.

Parveen, R., et al. (2017). "Malondialdehyde and antioxidant status in type 2 diabetic patients." Journal of Diabetes & Metabolic Disorders, 16(1), 28.

Downloads

Published

26-04-2025

How to Cite

Rita Kirana. (2025). MALONDIALDEHYDE (MDA) SEBAGAI PENANDA STRESS OKSIDATIF PADA TUBUH. Jurnal Cakrawala Ilmiah, 4(8), 1143–1154. Retrieved from https://www.bajangjournal.com/index.php/JCI/article/view/10133

Issue

Section

Articles